Toshiyasu Sasaoka

Toyama, 9300194, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Cinnamon plays a key role in the anti-obesity action of Hachimijiogan by ameliorating leptin resistance in the hypothalamus.

Cinnamon plays a key role in the anti-obesity action of Hachimijiogan by ameliorating leptin resistance in the hypothalamus.

Journal: The Journal of pharmacy and pharmacology

Published: February 05, 2026

Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice.

Protective role of soluble CD52 in obesity-associated steatotic liver disease and glucose dysregulation in mice.

Journal: Molecular metabolism

Published: October 21, 2025

Sleep-promoting effects of preproorexin C-terminal peptide in mice.

Sleep-promoting effects of preproorexin C-terminal peptide in mice.

Journal: Biochemical and biophysical research communications

Published: October 01, 2025

Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation.

Defective IgG Class Switching in the Spleen of TRAF5-Deficient Mice Reveals a Role for TRAF5 in CD40-Mediated B Cell Responses During Obesity-Associated Inflammation.

Journal: International journal of molecular sciences

Published: July 30, 2025

Early-life NAD+ deficiency programs skeletal muscle aging by sustained suppression of hyaluronic acid synthesis beginning in childhood.

Early-life NAD+ deficiency programs skeletal muscle aging by sustained suppression of hyaluronic acid synthesis beginning in childhood.

Journal: Cell reports

Published: May 16, 2025

Olfactory bulbectomy-induced impairment of lipid utilization leads to abnormal glucose metabolism in mice.

Olfactory bulbectomy-induced impairment of lipid utilization leads to abnormal glucose metabolism in mice.

Journal: PloS one

Published: March 24, 2025

Bromocriptine improves glucose tolerance in obese mice via central dopamine D2 receptor-independent mechanism.

Bromocriptine improves glucose tolerance in obese mice via central dopamine D2 receptor-independent mechanism.

Journal: PloS one

Published: August 08, 2024

Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes.

Deletion of platelet-derived growth factor receptor β suppresses tumorigenesis in metabolic dysfunction-associated steatohepatitis (MASH) mice with diabetes.

Journal: Scientific reports

Published: May 28, 2024

Platelet-derived growth factor signaling in pericytes promotes hypothalamic inflammation and obesity.

Platelet-derived growth factor signaling in pericytes promotes hypothalamic inflammation and obesity.

Journal: Molecular medicine (Cambridge, Mass.)

Published: October 05, 2023

Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice.

Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice.

Journal: European journal of pharmacology

Published: August 11, 2023

C-terminal peptide of preproorexin enhances brain-derived neurotrophic factor expression in rat cerebrocortical cells and recognition memory in mice.

C-terminal peptide of preproorexin enhances brain-derived neurotrophic factor expression in rat cerebrocortical cells and recognition memory in mice.

Journal: European journal of pharmacology

Published: July 24, 2023

Hachimijiogan, a traditional herbal medicine, modulates adipose cell function and ameliorates diet-induced obesity and insulin resistance in mice.

Hachimijiogan, a traditional herbal medicine, modulates adipose cell function and ameliorates diet-induced obesity and insulin resistance in mice.

Journal: Frontiers in pharmacology

Published: February 17, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026